Found: 9
Select item for more details and to access through your institution.
Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery.
- Published in:
- Scientific Reports, 2016, p. 21509, doi. 10.1038/srep21509
- By:
- Publication type:
- Article
Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5569, doi. 10.3390/cancers13215569
- By:
- Publication type:
- Article
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 848, doi. 10.3390/cancers11060848
- By:
- Publication type:
- Article
SRC Family Kinase Inhibition Through a New Pyrazolo[3,4- d]Pyrimidine Derivative as a Feasible Approach for Glioblastoma Treatment.
- Published in:
- Journal of Cellular Biochemistry, 2015, v. 116, n. 5, p. 856, doi. 10.1002/jcb.25042
- By:
- Publication type:
- Article
The Pyrazolo[3,4- d ]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 659, doi. 10.3390/biomedicines10030659
- By:
- Publication type:
- Article
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X.
- Published in:
- Molecules, 2019, v. 24, n. 21, p. 3988, doi. 10.3390/molecules24213988
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor Si409 Has In Vitro and In Vivo Anti-Tumor Activity Against Diffuse Large B-Cell Lymphoma.
- Published in:
- Pharmaceutical Chemistry Journal, 2023, v. 56, n. 12, p. 1616, doi. 10.1007/s11094-023-02836-x
- By:
- Publication type:
- Article
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198478
- By:
- Publication type:
- Article
Synthesis, Biological Activity, and ADME Properties of Novel S-DABOs/ N-DABOs as HIV Reverse Transcriptase Inhibitors.
- Published in:
- ChemMedChem, 2012, v. 7, n. 5, p. 883, doi. 10.1002/cmdc.201200056
- By:
- Publication type:
- Article